Literature DB >> 28362310

Seawater desalination and serum magnesium concentrations in Israel.

Gideon Koren1, Meital Shlezinger2, Rachel Katz3, Varda Shalev4, Yona Amitai2.   

Abstract

With increasing shortage of fresh water globally, more countries are consuming desalinated seawater (DSW). In Israel >50% of drinking water is now derived from DSW. Desalination removes magnesium, and hypomagnesaemia has been associated with increased cardiac morbidity and mortality. Presently the impact of consuming DSW on body magnesium status has not been established. We quantified changes in serum magnesium in a large population based study (n = 66,764), before and after desalination in regions consuming DSW and in regions where DSW has not been used. In the communities that switched to DSW in 2013, the mean serum magnesium was 2.065 ± 0.19 mg/dl before desalination and fell to 2.057 ± 0.19 mg/dl thereafter (p < 0.0001). In these communities 1.62% of subjects exhibited serum magnesium concentrations ≤1.6 mg/dl between 2010 and 2013. This proportion increased by 24% between 2010-2013 and 2015-2016 to 2.01% (p = 0.0019). In contrast, no such changes were recorded in the communities that did not consume DSW. Due to the emerging evidence of increased cardiac morbidity and mortality associated with hypomagnesaemia, it is vital to consider re-introduction of magnesium to DSW.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28362310     DOI: 10.2166/wh.2016.164

Source DB:  PubMed          Journal:  J Water Health        ISSN: 1477-8920            Impact factor:   1.744


  3 in total

1.  The Risk of CVDs from Desalinated Seawater: A Nested Case-Control Study.

Authors:  Juexin Shi; Yuan Liu; Qin Wang; Xiaojian Hu; Bixiong Ye; Shaoxia Dong
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

Review 2.  Magnesium in Aging, Health and Diseases.

Authors:  Mario Barbagallo; Nicola Veronese; Ligia J Dominguez
Journal:  Nutrients       Date:  2021-01-30       Impact factor: 5.717

3.  Identification of drugs associated with reduced severity of COVID-19 - a case-control study in a large population.

Authors:  Gil Lavie; Eytan Ruppin; Ariel Israel; Alejandro A Schäffer; Assi Cicurel; Kuoyuan Cheng; Sanju Sinha; Eyal Schiff; Ilan Feldhamer; Ameer Tal
Journal:  Elife       Date:  2021-07-27       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.